MedVi Reviews: Does It Really Work for Weight Loss?
Last updated: October 13, 2026
Quick Answer: MedVi is a telehealth platform that prescribes compounded GLP-1 medications, including semaglutide and tirzepatide, to adults seeking medically supervised weight loss. Based on aggregated customer reviews and clinical data on GLP-1 drugs, many users report meaningful weight loss, but results vary significantly and the platform has received notable complaints about billing, communication, and a February 2026 FDA warning letter. MedVi can work for weight loss when the medication is used correctly under proper supervision, but it is not the right fit for everyone.
Key Takeaways
- MedVi is a telehealth provider that prescribes compounded semaglutide and tirzepatide, not an over-the-counter supplement
- GLP-1 medications like semaglutide have strong clinical evidence for weight loss, with trials showing 10-15% average body weight reduction over 68 weeks [1]
- Real customer reviews are mixed: many users report significant weight loss, while others cite poor communication, billing issues, and inconsistent medication delivery [2]
- MedVi received an FDA warning letter in February 2026 related to compounded drug practices, which is a legitimate concern for prospective patients
- Pricing is generally more affordable than brand-name Ozempic or Wegovy, but cost perceptions are sharply divided among users [3]
- Side effects, including nausea, fatigue, and gastrointestinal discomfort, are common with GLP-1 medications and are reported by MedVi users as well [4]
- MedVi is best suited for adults with a BMI over 27 who have not responded to lifestyle changes alone and want a telehealth-based GLP-1 program
- People with a history of thyroid cancer, pancreatitis, or certain other conditions should not use GLP-1 medications through any provider, including MedVi
- Alternatives such as Hims/Hers Weight Loss, Found, and Ro Body offer comparable telehealth GLP-1 access and are worth comparing before committing
- Always consult a licensed healthcare provider before starting any GLP-1 program, regardless of the platform
What Is MedVi and How Does It Work for Weight Loss
MedVi is a telehealth platform, not a pill or supplement. It connects patients with licensed clinicians who can prescribe compounded GLP-1 receptor agonist medications, primarily semaglutide and tirzepatide, for weight management.
Here is how the process works:
- Complete an online intake form covering your health history, current medications, and weight loss goals
- Consult with a licensed clinician via the MedVi portal, either asynchronously or via video
- Receive a prescription for compounded semaglutide or tirzepatide if you qualify
- Medication is shipped to your door from a compounding pharmacy
- Follow-up check-ins are scheduled to adjust dosage and monitor progress
The medications MedVi prescribes work by mimicking GLP-1, a gut hormone that signals fullness to the brain, slows gastric emptying, and reduces appetite. To understand the full science behind these drugs, see our detailed guide on GLP-1 medications: what they are and how they work for weight loss and diabetes.
Important distinction: Multiple online searches for “MedVi weight loss pills” return results for an unrelated over-the-counter supplement brand. The MedVi reviewed here is the GLP-1 telehealth platform at medvi.org and getmedvi.com. These are entirely different products. [9]
MedVi targets adults with a BMI of 27 or higher who want prescription-grade weight loss support without navigating traditional in-person healthcare. The platform is available in most U.S. states, though availability can vary by location.
MedVi Reviews: Real Customer Results and Testimonials
Customer feedback on MedVi is genuinely mixed, though the majority of verified reviewers report positive weight loss outcomes when the medication is received and used consistently.
What positive reviewers say:
- Many users report losing 10 to 25 pounds within the first two to three months [2]
- Several reviewers highlight the convenience of telehealth access and home delivery as major advantages
- Users who have previously tried Ozempic or Wegovy through traditional providers often note that MedVi’s compounded version produced comparable results at a lower cost [3]
- One recurring theme in 2026 reviews is that the medication itself works well, with users crediting reduced appetite and fewer cravings as the primary drivers of their success [4]
What critical reviewers say:
- A recurring complaint involves delayed or missed shipments, leaving patients without medication mid-cycle [2]
- Some users report difficulty reaching customer support, with emails going unanswered for days or weeks [5]
- A subset of reviewers describe being charged for consultations or refills they never received
- A minority of users report minimal weight loss, which is consistent with the known variability in GLP-1 response across individuals
For a deeper look at patient experiences with compounded semaglutide specifically, our compounded semaglutide reviews: real patient stories article covers a broader range of platforms and outcomes.
Aggregate ratings as of late 2026: MedVi holds a mixed but leaning-positive rating across major review platforms, with Trustpilot scores varying between 3.2 and 4.1 depending on the specific MedVi domain reviewed [4][5]. ConsumerAffairs data shows a similar split, with a meaningful number of 5-star reviews alongside a notable cluster of 1-star complaints [2].
“The medication worked exactly as I hoped. I lost 18 pounds in 10 weeks. My only frustration was that one shipment was delayed by almost two weeks and no one responded to my emails.”, Verified ConsumerAffairs reviewer [2]
Is MedVi FDA Approved and Safe to Use
MedVi itself, as a telehealth platform, is not an FDA-regulated drug product. However, the medications it prescribes, compounded semaglutide and tirzepatide, operate in a more complex regulatory space.
The FDA warning letter (February 2026): MedVi received an FDA warning letter in February 2026. This is a significant development. The FDA has been actively scrutinizing telehealth platforms and compounding pharmacies that produce semaglutide and tirzepatide, particularly as the drug shortage designations for branded versions have changed. The warning letter does not mean MedVi’s medications are definitively unsafe, but it does signal that the FDA found compliance concerns worth addressing formally. Prospective patients should factor this into their decision. [10]
Are compounded GLP-1 medications safe?
Compounded medications are not FDA-approved in the same way brand-name drugs are, but they are legal when produced by an FDA-registered 503B outsourcing facility or a state-licensed 503A pharmacy under a valid prescription. The safety profile of the active ingredient, semaglutide, is well-established through extensive clinical trials. The concern with compounded versions is consistency of dosing and sterility, which depends heavily on the compounding pharmacy used.
Known safety considerations for GLP-1 medications:
- Not appropriate for people with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2
- Should be avoided in people with a history of pancreatitis
- Requires caution in people with severe kidney or liver impairment
- Not approved for use during pregnancy or breastfeeding
MedVi’s intake process is designed to screen for these contraindications, but patients should always disclose their full medical history accurately.
Does MedVi Actually Work: Scientific Evidence for GLP-1 Weight Loss
The evidence that GLP-1 receptor agonists produce meaningful weight loss is among the strongest in obesity medicine. The question of whether MedVi specifically works is really two questions: does the medication class work, and does MedVi deliver it reliably?
Clinical evidence for semaglutide:
The STEP 1 trial, published in the New England Journal of Medicine, found that adults using semaglutide 2.4 mg weekly lost an average of 14.9% of body weight over 68 weeks, compared to 2.4% in the placebo group. This is the same active ingredient in MedVi’s primary offering. [1][7]
Clinical evidence for tirzepatide:
The SURMOUNT-1 trial showed even stronger results, with participants losing up to 20.9% of body weight at the highest dose. MedVi also offers tirzepatide-based programs. For a full breakdown of patient experiences with this medication, see our tirzepatide reviews by patients guide.
What affects whether MedVi works for you:
- Consistent medication use without gaps in supply
- Adherence to the recommended dosage escalation schedule
- Supporting lifestyle changes, including diet and movement
- Individual metabolic response, which varies significantly between people
The medication works. The platform’s ability to deliver it consistently is where user experiences diverge most sharply. [3]
MedVi Pricing and Subscription Cost
MedVi positions itself as a more affordable alternative to brand-name GLP-1 medications. Brand-name Wegovy can cost over $1,300 per month without insurance, making compounded alternatives attractive to patients paying out of pocket.
For a full breakdown of what semaglutide costs across different providers in 2026, see our guide on how much semaglutide costs in 2026.
General pricing structure (as of 2026):
| Program | Estimated Monthly Cost | Medication Type |
|---|---|---|
| MedVi Semaglutide | Lower than brand-name; varies by dose | Compounded semaglutide |
| MedVi Tirzepatide | Varies by dose tier | Compounded tirzepatide |
| Brand Wegovy (no insurance) | $1,300+ (retail) | FDA-approved semaglutide |
| Brand Zepbound (no insurance) | $1,000+ (retail) | FDA-approved tirzepatide |
Cost perceptions among MedVi users are sharply divided. Some reviewers consider it excellent value, while others feel the service quality does not justify even the lower price point when shipments are delayed or support is unresponsive. [3][6]
For more cost comparisons across telehealth GLP-1 providers, our guide to the least expensive GLP-1 options for weight loss covers the full landscape.
Start your MedVi consultation today and see if you qualify for a GLP-1 program
MedVi Side Effects and Safety Concerns
GLP-1 medications, including those prescribed through MedVi, carry a well-documented side effect profile. Most side effects are gastrointestinal and tend to be most pronounced during the dose escalation phase.
Commonly reported side effects by MedVi users:
- Nausea (most frequently reported, especially in weeks 1-4) [4]
- Fatigue and low energy, particularly early in treatment
- Constipation or diarrhea
- Reduced appetite, which is the intended mechanism but can feel extreme for some users
- Injection site reactions (redness, mild swelling)
- Headaches during the adjustment period
Less common but serious concerns:
- Pancreatitis (rare but requires immediate medical attention if suspected)
- Gallbladder issues, including gallstones
- Rapid heart rate
MedVi-specific safety concern: The February 2026 FDA warning letter introduces an additional layer of uncertainty around the quality and consistency of MedVi’s compounded medications. Until MedVi publicly demonstrates full compliance with FDA requirements, this is a legitimate risk factor to weigh. [10]
Most users who experience side effects describe them as manageable and temporary. The key is having accessible medical support to adjust dosing if side effects become severe, which is an area where some MedVi users have reported frustration with response times. [5]
Who Should Use MedVi and Who Should Not
MedVi is a good fit for a specific type of patient. It is not universally appropriate.
Ideal candidates for MedVi:
- Adults with a BMI of 27 or higher, especially those with weight-related health conditions
- People who have tried diet and exercise without achieving sustainable results
- Individuals who cannot afford or access brand-name GLP-1 medications through traditional healthcare
- Patients comfortable with telehealth-based care and self-administered injections
- Those who are proactive about following up and can manage potential communication delays
Who should avoid MedVi or proceed with caution:
- People with a personal or family history of medullary thyroid carcinoma or MEN2
- Anyone with a history of pancreatitis or severe gastrointestinal disease
- Pregnant or breastfeeding women
- Individuals taking medications with known GLP-1 interactions (discuss with a physician first)
- Patients who need frequent, responsive medical support and cannot tolerate communication delays
- Anyone who feels uncomfortable with the regulatory uncertainty introduced by the FDA warning letter
Choose MedVi if: You are a generally healthy adult with obesity or overweight, comfortable with telehealth, and primarily motivated by cost savings over brand-name GLP-1 medications.
Choose an alternative if: You have complex medical needs, require close monitoring, or prioritize FDA-approved branded medications and fully responsive clinical support.
How Long Does It Take to See Results With MedVi
Most MedVi users who respond to GLP-1 therapy begin noticing appetite suppression within the first one to two weeks. Visible weight loss typically becomes apparent between weeks four and eight. [7]
General timeline based on GLP-1 clinical data and user reports:
- Weeks 1-4: Appetite reduction, early nausea, minor weight changes (1-5 lbs for most)
- Weeks 4-12: Meaningful weight loss begins, often 5-15 lbs depending on starting weight and dose
- Months 3-6: Continued steady loss; many users report 10-20% body weight reduction in this window [1]
- Month 6+: Results plateau for some; dose adjustments or medication changes may be needed
Results depend heavily on consistent medication delivery, which has been a pain point for some MedVi users who experienced shipping delays. A two-week gap in medication can significantly disrupt progress and cause side effects to restart when the medication resumes.
Check if you qualify for MedVi’s GLP-1 weight loss program here
MedVi vs Other Weight Loss Telehealth Platforms: Which Is Better
MedVi competes directly with several telehealth platforms offering GLP-1 prescriptions. Each has distinct strengths and weaknesses.
MedVi vs Hims/Hers Weight Loss: Hims offers a polished app experience and strong brand recognition. MedVi tends to be more affordable at comparable dose levels, but Hims generally receives better marks for customer support responsiveness. See our full Hims weight loss review for a detailed comparison.
MedVi vs Found: Found includes behavioral coaching alongside medication, which may improve long-term outcomes. MedVi focuses more narrowly on the medication itself, which suits patients who prefer a streamlined, lower-cost approach.
MedVi vs Ro Body: Ro Body offers access to brand-name Ozempic in some cases and has a strong telehealth infrastructure. It tends to cost more but may offer more clinical oversight.
MedVi vs Kind Patches: Kind Patches takes a different approach with GLP-1 delivery via transdermal patches rather than injections. See our Kind Patches GLP-1 weight loss review for a full breakdown of how this compares.
Bottom line on comparisons: MedVi’s primary competitive advantage is cost. If price is your main driver and you are comfortable managing some service variability, MedVi is worth considering. If you want a more full-service experience, alternatives like Hims or Found may serve you better.
Common Mistakes People Make With MedVi
Several patterns emerge from negative MedVi reviews that are avoidable with the right preparation.
Mistake 1: Not following up proactively on shipments. MedVi’s shipping and communication issues are well-documented. Users who wait passively for their medication often experience longer delays than those who contact support preemptively.
Mistake 2: Expecting immediate results. GLP-1 medications require a dose escalation period. Users who expect dramatic weight loss in week one are frequently disappointed and may abandon the program prematurely.
Mistake 3: Not disclosing full medical history. Incomplete intake forms can result in prescriptions that are not appropriate for a patient’s actual health situation, increasing safety risks.
Mistake 4: Confusing MedVi the telehealth platform with “MedVi weight loss pills.” The supplement brand that appears in some online searches is unrelated to the GLP-1 telehealth service. [9]
Mistake 5: Stopping medication abruptly. Weight regain after stopping GLP-1 medications is well-documented in clinical literature. Patients should discuss a tapering or transition plan with their clinician rather than stopping cold.
Avoid these mistakes by starting with a proper MedVi consultation
MedVi Refund Policy and Customer Service Complaints
MedVi’s refund policy and customer service quality are among the most common sources of complaints in reviews. MedVi does not appear to offer straightforward refunds on medication once it has been shipped, which aligns with standard practice for prescription medications but frustrates users who received delayed or incorrect shipments. [6]
Common customer service complaints:
- Slow email response times, sometimes exceeding 5-7 business days
- Difficulty accessing the patient portal after initial sign-up
- Charges appearing before medication is received
- Difficulty canceling subscriptions [5]
What to do if you have a complaint:
- Document all communications with dates and screenshots
- Contact MedVi through multiple channels (email and portal messaging)
- If unresolved, file a complaint with your state’s medical board or the BBB
- Dispute unauthorized charges with your credit card provider if applicable
The BBB profile for MedVi reflects a pattern of billing and communication complaints that prospective customers should review before enrolling. This does not mean MedVi is fraudulent, but it does mean patients should enter the program with clear expectations about service responsiveness.
MedVi Alternatives for Weight Loss
If MedVi does not feel like the right fit after reviewing the evidence, several alternatives are worth considering.
Telehealth GLP-1 alternatives:
- Hims/Hers Weight Loss – Strong app experience, responsive support, slightly higher cost
- Found – Medication plus coaching, good for patients who want behavioral support
- Ro Body – Access to brand-name options in some cases, strong clinical infrastructure
- Shed – See our Shed GLP-1 reviews for a focused comparison
For patients focused on cost: Our guide to RX medications for weight loss in 2026 covers the full spectrum of prescription options, including how to find the most affordable path to GLP-1 therapy.
For patients considering which GLP-1 is most effective: See our analysis of which GLP-1 medication works best for weight loss to understand how semaglutide and tirzepatide compare head-to-head.
Non-prescription alternatives: For adults who do not qualify for or want GLP-1 medications, structured diet programs and evidence-based supplements exist, though none match the clinical efficacy of GLP-1 drugs. Our review of Leptozan weight loss supplement covers one such option honestly.
Explore MedVi’s GLP-1 programs and find the right fit for your goals
Pros and Cons of MedVi
| Pros | Cons |
|---|---|
| Access to clinically proven GLP-1 medications | FDA warning letter received in February 2026 |
| More affordable than brand-name Ozempic or Wegovy | Customer service response times frequently criticized |
| Telehealth convenience, no in-person visits required | Shipping delays reported by multiple users |
| Both semaglutide and tirzepatide options available | Compounded medications are not FDA-approved products |
| Many users report significant, sustained weight loss | Billing complaints and cancellation difficulties noted |
| Available in most U.S. states | Results vary; not effective for all users |
Conclusion
The core question behind every “med vi reviews does medvi work” search is simple: can this platform actually help you lose weight? The honest answer is yes, with important caveats.
The GLP-1 medications MedVi prescribes, semaglutide and tirzepatide, are backed by some of the strongest clinical evidence in weight loss medicine. When delivered consistently and used correctly, they produce real, meaningful results for most patients. Many MedVi users in 2026 confirm this with their own outcomes.
The platform’s weaknesses, including the February 2026 FDA warning letter, documented shipping delays, and customer service gaps, are real concerns that should not be dismissed. They do not make MedVi a scam, but they do mean you should enter the program with clear expectations and a proactive approach to managing your care.
Actionable next steps:
- Review your full medical history and confirm you have no contraindications to GLP-1 therapy before applying
- Compare MedVi’s current pricing against at least two competitors before committing
- Read recent reviews on Trustpilot and ConsumerAffairs to get a current picture of service quality
- If you proceed, set calendar reminders to follow up on shipments proactively rather than waiting
- Discuss any concerns about the FDA warning letter directly with the MedVi clinician during your consultation
Ready to see if MedVi’s GLP-1 program is right for you? Start your consultation here
If you want to explore the full range of GLP-1 options before deciding, our guide to GLP-1 transformation: what it really does to your body, weight, and metabolism is a strong starting point.
Get started with MedVi today and take the first step toward your weight loss goals
Frequently Asked Questions
How long before I see results with MedVi? Most users notice appetite suppression within the first one to two weeks. Visible weight loss typically begins between weeks four and eight, with more significant results appearing between months two and four of consistent use. [7]
Can I take MedVi’s semaglutide with other supplements or medications? GLP-1 medications can interact with oral medications by slowing gastric emptying, which affects absorption timing. Always disclose all medications and supplements to your MedVi clinician during intake. Do not combine with other weight loss medications without medical guidance.
Are there side effects with MedVi’s GLP-1 medications? Yes. Nausea, fatigue, constipation, and reduced appetite are the most commonly reported side effects, particularly during the dose escalation phase. Most users describe these as manageable and temporary. Serious side effects like pancreatitis are rare but require immediate medical attention. [4]
Is MedVi safe for long-term use? Long-term safety data for semaglutide extends to several years in clinical trials, with a generally favorable profile. The concern specific to MedVi is the quality consistency of compounded medications, particularly given the 2026 FDA warning letter. Long-term use should involve regular check-ins with a clinician. [10]
How does MedVi compare to Ozempic or Wegovy? MedVi uses the same active ingredient as Ozempic and Wegovy (semaglutide) but in a compounded form, which is significantly cheaper. Brand-name versions are FDA-approved finished drug products with guaranteed consistency. Compounded versions are legal under specific conditions but carry more regulatory uncertainty. [1]
Can I use MedVi if I have type 2 diabetes? Semaglutide is FDA-approved for type 2 diabetes management under the brand name Ozempic. However, MedVi’s program is positioned for weight loss. If you have type 2 diabetes, discuss this with both your primary care physician and the MedVi clinician to ensure appropriate monitoring and avoid drug interactions with diabetes medications.
What if MedVi does not work for me? A small percentage of patients are non-responders to GLP-1 medications. If you see no results after 12-16 weeks of consistent use at an appropriate dose, discuss switching medications (for example, from semaglutide to tirzepatide) with your clinician. MedVi’s refund policy is limited once medication has shipped, so document your experience carefully. [6]
Is MedVi a reputable company? MedVi has a mixed reputation. It has many satisfied customers who report significant weight loss, but also a documented pattern of billing and communication complaints, and a February 2026 FDA warning letter. It is not a fraudulent operation, but it is not without legitimate concerns. Prospective patients should review current BBB and Trustpilot feedback before enrolling. [5][10]
Does MedVi work for different diet types, like keto or vegan? GLP-1 medications work independently of specific diet types. MedVi does not mandate a particular diet, though clinicians may provide general nutritional guidance. The appetite-suppressing effect of semaglutide and tirzepatide can complement keto, vegan, Mediterranean, or other dietary approaches. The medication’s efficacy is not diet-dependent, though combining it with a calorie-appropriate eating pattern accelerates results. [7]
Have more questions? Speak with a MedVi clinician directly
References
[1] USA Today – https://www.usatoday.com/story/life/health-wellness/medvi-reviews/90183552007/ [2] MedVi ConsumerAffairs – https://www.consumeraffairs.com/health/medvi.html [3] MedVi Reviews – ManyTreatments – https://manytreatments.com/brands/medvi/reviews [4] MedVi Trustpilot (medvi.org) – https://www.trustpilot.com/review/medvi.org [5] MedVi Trustpilot (getmedvi.com) – https://www.trustpilot.com/review/getmedvi.com [6] MedVi ConsumerAffairs Page 7 – https://www.consumeraffairs.com/health/medvi.html?page=7 [7] MedVi Weight Loss Reviews – IvyRx – https://www.ivyrx.com/blog/medvi-weight-loss-reviews [8] MedVi ConsumerAffairs Page 8 – https://www.consumeraffairs.com/health/medvi.html?page=8 [9] MedVi Weight Loss Pills – Flapen Research – https://flapen.com/research/us/health-household/medvi-weight-loss-pills [10] MedVi GLP-1 Review 2026 – Your Health Magazine – https://yourhealthmagazine.net/article/reviews/medvi-glp-1-review-2026-is-it-effective-for-weight-loss/
Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a licensed healthcare provider before starting any weight loss medication or program. Individual results vary.
Affiliate Disclosure: Some links in this article may be affiliate links. We may earn a commission if you purchase through these links, at no additional cost to you. This does not influence our editorial assessments.
With over 13 years of experience in holistic health blogging, I aim to help you navigate your wellness journey with honest insights, expert-backed advice, and a sprinkle of real-world practicality.
Certified Wellness Writer | Herbal Nutrition Advocate | Wellness Research Enthusiast
